世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

幹細胞製造市場:製品毎(HSC、MSC、iPSC、ESC、器具。メディア、消耗品)、用途毎(研究、目標識別、治療:自己・同種間移植、細胞バンク)、エンドユーザ毎(医薬、病院) - 2023年までの世界市場予測

Stem Cell Manufacturing Market by Product (HSCs, MSCs, iPSCs, ESCs, Instruments, Media, Consumables), Application (Research, Target Identification, Therapy (Autologous, Allogeneic), Cell Banks), End User (Pharma, Hospitals) - Global Forecast to 2023

 

出版社 出版年月電子版価格 ページ数図表数
MarketsandMarkets
マーケッツアンドマーケッツ
2018年3月US$5,650
シングルユーザライセンス
167 102

サマリー

幅広い市場に関する調査レポートを出版しているマーケッツアンドマーケッツ(MarketsandMarkets)の幹細胞製造市場に関する調査レポートです。

Stem cell manufacturing market projected to grow at a CAGR of 6.3%

The stem cell manufacturing market is projected to reach USD 14.61 billion by 2023 from USD 10.75 billion in 2018, at a CAGR of 6.3%. The growing public-private investments and funding in stem cell-based research, rising public awareness regarding about the therapeutic potency of stem cell products, and development of advanced genomic analysis techniques for quality control during stem cell manufacturing are the major factors driving the stem cell manufacturing market. Factor such as the significant operational costs associated with stem cell manufacturing and banking is limiting the growth of the market to a certain extent.

The stem cell line segment is expected to witness the highest growth during the forecast period

On the basis of product, the stem cell lines segment is expected to register the highest growth rate during the forecast period, due to the growing demand for functionally potent stem cell lines in research and the development of innovative stem cell culture & preservation techniques.
The research applications segment accounted for the largest share of the stem cell manufacturing in 2017

Based on application, the global stem cell manufacturing market is segmented into research applications, clinical applications, and cell and tissue banking. The research applications segment accounted for the largest share of the stem cell manufacturing in 2017. The growth in this segment is primarily attributed to the increasing focus on stem cell-based research, growing awareness about the therapeutic potency of stem cells, and public-private funding to support product development & commercialization.

The cell and tissue banks segment is poised to be the fastest growing during the forecast period

On the basis of end user, the cell and tissue banks segment is expected to register the highest growth rate during the forecast period, owing to the growing number of stem cell transplantation procedures, ongoing advancements in stem cell & tissue processing and storage methodologies, and growing applications of stem cells in disease treatment.  

Asia Pacific is expected to register the highest growth rate during the forecast period

Geographically, the stem cell manufacturing market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. Asia Pacific is expected to register the highest growth rate during the forecast period owing to a supportive regulatory framework for stem cell research & manufacturing and ongoing expansion & modernization of healthcare infrastructure across emerging Asian countries.

Breakdown of supply-side primary interviews: by company type, designation, and region:

• By Company Type - Tier 1 – 48%, Tier 2 – 40% and Tier 3 – 12%
• By Designation – C-level – 26%, Director-level – 30%, Others – 44%
• By Region – North America - 34%, Europe – 26%, APAC – 23%, and RoW – 17%

The global stem cell manufacturing market is competitive, with a large number of global and local players. In 2016, the market was dominated by Thermo Fisher Scientific (US), Merck Group (Germany), and Becton, Dickinson and Company (US). New product launches, upgrades, approvals, agreements, partnerships, and collaborations were the major strategies adopted by market players to achieve growth in the market.  

Research Coverage

This report studies the stem cell manufacturing market, based on product, application, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for the market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions.

Reasons to Buy the Report:

This research report focuses on various levels of analysis—industry trends, market share analysis of top players, and company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging and high-growth segments of the stem cell manufacturing market, and high-growth regions and countries and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn can help firms garner greater market shares. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on product portfolios offered by the major players in the stem cell manufacturing market. The report analyzes the stem cell manufacturing market based on product, application, end user, and region
• New Product Development: Detailed insights on the research and development activities and new product launches in the stem cell manufacturing market
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various stem cell manufacturing products across geographies
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the stem cell manufacturing market
• Competitive Assessment: In-depth assessment of market ranking, strategies, product portfolios, distribution networks, and providers capabilities of leading players in the stem cell manufacturing market
 



目次

1 INTRODUCTION 13
1.1 OBJECTIVES OF THE STUDY 13
1.2 MARKET DEFINITION 13
1.2.1 MARKETS COVERED 14
1.2.2 GEOGRAPHIC SCOPE 15
1.2.3 YEARS CONSIDERED FOR THE STUDY 15
1.3 CURRENCY USED 16
1.4 MARKET STAKEHOLDERS 16
2 RESEARCH METHODOLOGY 17
2.1 RESEARCH DATA 17
2.1.1 SECONDARY DATA 18
2.1.1.1 Secondary sources 19
2.1.2 PRIMARY DATA 20
2.1.2.1 Breakdown of primaries 20
2.1.2.2 Key data from primary sources 21
2.2 MARKET SIZE ESTIMATION 22
2.2.1 BOTTOM-UP APPROACH 22
2.2.2 TOP-DOWN APPROACH 23
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 24
2.4 RESEARCH ASSUMPTIONS 25
2.5 RESEARCH LIMITATIONS 25
3 EXECUTIVE SUMMARY 26
4 PREMIUM INSIGHTS 30
4.1 STEM CELL MANUFACTURING: MARKET OVERVIEW (2018) 30
4.2 GLOBAL STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2018 30
4.3 STEM CELL MANUFACTURING MARKET, BY APPLICATION AND REGION (2018) 31
4.4 STEM CELL MANUFACTURING MARKET, BY END USER (2018 VS 2023) 32
4.5 GEOGRAPHIC SNAPSHOT: STEM CELL MANUFACTURING MARKET (2017) 33

5 MARKET OVERVIEW 34
5.1 INTRODUCTION 34
5.2 MARKET DYNAMICS 34
5.2.1 MARKET DRIVERS 35
5.2.1.1 Growing public-private investments and funding in stem cell-based research 35
5.2.1.2 Growing public awareness about the therapeutic potency of stem cell products 36
5.2.1.3 Development of advanced genomic analysis techniques for quality control during stem cell manufacturing 36
5.2.1.4 Technological advancements in stem cell manufacturing and preservation 37
5.2.1.5 Evolving regulatory frameworks for stem cell therapeutics in the US and Europe 38
5.2.2 MARKET RESTRAINTS 39
5.2.2.1 Significant operational costs associated with stem cell manufacturing and banking 39
5.2.3 MARKET OPPORTUNITIES 40
5.2.3.1 Increased market focus on embryonic stem cells and induced pluripotent stem cells 40
5.2.3.2 Supportive government regulations across developing countries 40
5.2.4 MARKET CHALLENGES 41
5.2.4.1 Technical limitations associated with manufacturing scale-up 41
5.2.4.2 Socio-ethical concerns related to the use of allogenic and human embryonic stem cells 41
5.2.5 RESEARCH PIPELINE ANALYSIS: STEM CELL-BASED PRODUCTS/THERAPIES 42
6 STEM CELL MANUFACTURING MARKET, BY PRODUCT 46
6.1 INTRODUCTION 47
6.2 CULTURE MEDIA 48
6.3 CONSUMABLES 48
6.4 INSTRUMENTS 49
6.4.1 BIOREACTORS AND INCUBATORS 50
6.4.2 CELL SORTERS 51
6.4.3 OTHER INSTRUMENTS 52
6.5 STEM CELL LINES 53
6.5.1 HEMATOPOIETIC STEM CELLS 54
6.5.2 MESENCHYMAL STEM CELLS 55
6.5.3 INDUCED PLURIPOTENT STEM CELLS 55
6.5.4 EMBRYONIC STEM CELLS 57
6.5.5 NEURAL STEM CELLS 58
6.5.6 MULTIPOTENT ADULT PROGENITOR STEM CELLS 58

7 STEM CELL MANUFACTURING MARKET, BY APPLICATION 60
7.1 INTRODUCTION 61
7.2 RESEARCH APPLICATIONS 62
7.2.1 DRUG DISCOVERY AND DEVELOPMENT 63
7.2.2 LIFE SCIENCE RESEARCH 64
7.3 CLINICAL APPLICATIONS 65
7.3.1 ALLOGENIC STEM CELL THERAPY 66
7.3.2 AUTOLOGOUS STEM CELL THERAPY 67
7.4 CELL AND TISSUE BANKING APPLICATIONS 68
8 STEM CELL MANUFACTURING MARKET, BY END USER 70
8.1 INTRODUCTION 71
8.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 72
8.3 HOSPITALS AND SURGICAL CENTERS 73
8.4 ACADEMIC INSTITUTES, RESEARCH LABORATORIES, AND CONTRACT RESEARCH ORGANIZATIONS 74
8.5 CELL BANKS AND TISSUE BANKS 75
8.6 OTHER END USERS 76
9 STEM CELL MANUFACTURING MARKET, BY REGION 77
9.1 INTRODUCTION 78
9.2 NORTH AMERICA 79
9.2.1 US 84
9.3 EUROPE 85
9.4 ASIA PACIFIC 90
9.5 REST OF THE WORLD 95
10 COMPETITIVE LANDSCAPE 100
10.1 OVERVIEW 100
10.2 MARKET RANKING (2016) 100
10.3 COMPETITIVE SCENARIO 101
10.3.1 PRODUCT LAUNCHES, UPGRADES, AND APPROVALS 102
10.3.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 102
10.3.3 MERGERS AND ACQUISITIONS 103
10.3.4 EXPANSIONS 104

11 COMPANY PROFILES 105
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
11.1 ANTEROGEN 105
11.2 BECTON, DICKINSON AND COMPANY (BD) 106
11.3 BIO-RAD LABORATORIES 110
11.4 CELLULAR DYNAMICS INTERNATIONAL (A SUBSIDIARY OF FUJIFILM HOLDINGS CORPORATION) 114
11.5 HOLOSTEM TERAPIE AVANZATE 118
11.6 LONZA GROUP 119
11.7 MEDIPOST 122
11.8 MERCK GROUP 124
11.9 MILTENYI BIOTEC 129
11.10 OSIRIS THERAPEUTICS 132
11.11 PHARMICELL 133
11.12 PLURISTEM THERAPEUTICS 134
11.13 STEMCELL TECHNOLOGIES 137
11.14 TAKARA BIO GROUP 142
11.15 THERMO FISHER SCIENTIFIC 147
*Details on Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.
12 APPENDIX 156
12.1 DISCUSSION GUIDE 156
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 160
12.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 162
12.4 AVAILABLE CUSTOMIZATIONS 163
12.5 RELATED REPORTS 164
12.6 AUTHOR DETAILS 165

 

LIST OF TABLES

TABLE 1 KEY GENOME-BASED CELL ANALYSIS PRODUCTS LAUNCHED DURING 2014–2017 37
TABLE 2 STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2016-2023 (USD MILLION) 47
TABLE 3 STEM CELL MANUFACTURING MARKET FOR CULTURE MEDIA, BY REGION,
2016-2023 (USD MILLION) 48
TABLE 4 STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY REGION,
2016-2023 (USD MILLION) 49
TABLE 5 STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE,
2016-2023 (USD MILLION) 49
TABLE 6 STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY REGION,
2016-2023 (USD MILLION) 50
TABLE 7 STEM CELL MANUFACTURING MARKET FOR BIOREACTORS & INCUBATORS,
BY REGION, 2016-2023 (USD MILLION) 51
TABLE 8 STEM CELL MANUFACTURING MARKET FOR CELL SORTERS, BY REGION,
2016-2023 (USD MILLION) 52
TABLE 9 STEM CELL MANUFACTURING MARKET FOR OTHER INSTRUMENTS, BY REGION, 2016-2023 (USD MILLION) 52
TABLE 10 STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE,
2016-2023 (USD MILLION) 53
TABLE 11 STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY REGION,
2016-2023 (USD MILLION) 54
TABLE 12 HEMATOPOIETIC STEM CELLS MARKET, BY REGION, 2016-2023 (USD MILLION) 54
TABLE 13 MESENCHYMAL STEM CELLS MARKET, BY REGION, 2016-2023 (USD MILLION) 55
TABLE 14 KEY EXPANSION AND DIFFERENTIATION TECHNOLOGIES TO EXTRACT HUMAN-INDUCED PLURIPOTENT STEM CELL LINES 56
TABLE 15 INDUCED PLURIPOTENT STEM CELLS MARKET, BY REGION,
2016-2023 (USD MILLION) 57
TABLE 16 EMBRYONIC STEM CELLS MARKET, BY REGION, 2016-2023 (USD MILLION) 57
TABLE 17 NEURAL STEM CELLS MARKET, BY REGION, 2016-2023 (USD MILLION) 58
TABLE 18 MULTIPOTENT ADULT PROGENITOR STEM CELLS MARKET, BY REGION,
2016-2023 (USD MILLION) 59
TABLE 19 STEM CELL MANUFACTURING MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 61
TABLE 20 STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2016–2023 (USD MILLION) 62
TABLE 21 STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS,
BY REGION, 2016–2023 (USD MILLION) 63
TABLE 22 STEM CELL MANUFACTURING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2016–2023 (USD MILLION) 64
TABLE 23 STEM CELL MANUFACTURING MARKET FOR LIFE SCIENCE RESEARCH, BY REGION, 2016–2023 (USD MILLION) 65
TABLE 24 STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS,
BY TYPE, 2016–2023 (USD MILLION) 65
TABLE 25 STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2016–2023 (USD MILLION) 66
TABLE 26 STEM CELL MANUFACTURING MARKET FOR ALLOGENIC STEM CELL THERAPY,
BY REGION, 2016–2023 (USD MILLION) 67
TABLE 27 STEM CELL MANUFACTURING MARKET FOR AUTOLOGOUS STEM CELL THERAPY, BY REGION, 2016–2023 (USD MILLION) 68
TABLE 28 STEM CELL MANUFACTURING MARKET FOR CELL & TISSUE BANKING APPLICATIONS, BY REGION, 2016–2023 (USD MILLION) 69
TABLE 29 STEM CELL MANUFACTURING MARKET, BY END USER, 2016–2023 (USD MILLION) 71
TABLE 30 STEM CELL MANUFACTURING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2016–2023 (USD MILLION) 72
TABLE 31 STEM CELL MANUFACTURING MARKET FOR HOSPITALS AND SURGICAL CENTERS, BY REGION, 2016–2023 (USD MILLION) 73
TABLE 32 STEM CELL MANUFACTURING MARKET FOR ACADEMIC INSTITUTES, RESEARCH LABORATORIES, AND CONTRACT RESEARCH ORGANIZATIONS, BY REGION,
2016–2023 (USD MILLION) 74
TABLE 33 STEM CELL MANUFACTURING MARKET FOR CELL BANKS AND TISSUE BANKS,
BY REGION, 2016–2023 (USD MILLION) 75
TABLE 34 STEM CELL MANUFACTURING MARKET FOR OTHER END USERS, BY REGION, 2016–2023 (USD MILLION) 76
TABLE 35 STEM CELL MANUFACTURING MARKET, BY REGION, 2016–2023 (USD MILLION) 79
TABLE 36 NORTH AMERICA: STEM CELL MANUFACTURING MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 81
TABLE 37 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2016–2023 (USD MILLION) 81
TABLE 38 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS,
BY TYPE, 2016–2023 (USD MILLION) 82
TABLE 39 NORTH AMERICA: STEM CELL MANUFACTURING MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 82
TABLE 40 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2016–2023 (USD MILLION) 82
TABLE 41 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2016–2023 (USD MILLION) 83
TABLE 42 NORTH AMERICA: STEM CELL MANUFACTURING MARKET, BY END USER,
2016–2023 (USD MILLION) 83
TABLE 43 US: STEM CELL MANUFACTURING MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 84
TABLE 44 US: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES,
BY TYPE, 2016–2023 (USD MILLION) 85
TABLE 45 EUROPE: STEM CELL MANUFACTURING MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 87
TABLE 46 EUROPE: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES,
BY TYPE, 2016–2023 (USD MILLION) 87
TABLE 47 EUROPE: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS,
BY TYPE, 2016–2023 (USD MILLION) 88
TABLE 48 EUROPE: STEM CELL MANUFACTURING MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 88
TABLE 49 EUROPE: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2016–2023 (USD MILLION) 88
TABLE 50 EUROPE: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS,
BY TYPE, 2016–2023 (USD MILLION) 89
TABLE 51 EUROPE: STEM CELL MANUFACTURING MARKET, BY END USER,
2016–2023 (USD MILLION) 89
TABLE 52 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 92
TABLE 53 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES,
BY TYPE, 2016–2023 (USD MILLION) 92
TABLE 54 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS,
BY TYPE, 2016–2023 (USD MILLION) 93
TABLE 55 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 93
TABLE 56 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2016–2023 (USD MILLION) 93
TABLE 57 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2016–2023 (USD MILLION) 94
TABLE 58 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET, BY END USER,
2016–2023 (USD MILLION) 94
TABLE 59 ROW: STEM CELL MANUFACTURING MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 97
TABLE 60 ROW: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES,
BY TYPE, 2016–2023 (USD MILLION) 97
TABLE 61 ROW: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE,
2016–2023 (USD MILLION) 98
TABLE 62 ROW: STEM CELL MANUFACTURING MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 98
TABLE 63 ROW: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS,
BY TYPE, 2016–2023 (USD MILLION) 98
TABLE 64 ROW: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS,
BY TYPE, 2016–2023 (USD MILLION) 99
TABLE 65 ROW: STEM CELL MANUFACTURING MARKET, BY END USER,
2016–2023 (USD MILLION) 99
TABLE 66 KEY PRODUCT LAUNCHES, UPGRADES, AND APPROVALS, 2014–2017 102
TABLE 67 KEY AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2014–2017 102
TABLE 68 KEY MERGERS AND ACQUISITIONS, 2014–2017 103
TABLE 69 KEY EXPANSIONS, 2014–2017 104

 

LIST OF FIGURES

FIGURE 1 GLOBAL STEM CELL MANUFACTURING MARKET: RESEARCH METHODOLOGY STEPS 17
FIGURE 2 RESEARCH DESIGN 18
FIGURE 3 STEM CELL MANUFACTURING MARKET: BOTTOM-UP APPROACH 22
FIGURE 4 STEM CELL MANUFACTURING MARKET: TOP-DOWN APPROACH 23
FIGURE 5 DATA TRIANGULATION METHODOLOGY 24
FIGURE 6 CULTURE MEDIA SEGMENT TO DOMINATE THE GLOBAL STEM CELL MANUFACTURING MARKET DURING FORECAST PERIOD 26
FIGURE 7 RESEARCH APPLICATIONS SEGMENT TO DOMINATE THE STEM CELL MANUFACTURING MARKET DURING FORECAST PERIOD 27
FIGURE 8 CELL AND TISSUE BANKS TO BE THE FASTEST-GROWING END-USER SEGMENT DURING 2018–2023 28
FIGURE 9 ASIA PACIFIC TO GROW AT THE HIGHEST RATE IN THE FORECAST PERIOD 29
FIGURE 10 RISING PUBLIC-PRIVATE INVESTMENTS AND FUNDING FOR STEM CELL-BASED RESEARCH TO DRIVE MARKET GROWTH 30
FIGURE 11 CULTURE MEDIA SEGMENT TO DOMINATE THE GLOBAL STEM CELL MANUFACTURING MARKET DURING THE FORECAST PERIOD 30
FIGURE 12 NORTH AMERICA TO DOMINATE THE STEM CELL MANUFACTURING MARKET,
BY APPLICATION, IN 2018 31
FIGURE 13 CELL BANKS AND TISSUE BANKS TO BE FASTEST-GROWING SEGMENT DURING THE FORECAST PERIOD 32
FIGURE 14 NORTH AMERICA TO DOMINATE THE GLOBAL STEM CELL MANUFACTURING MARKET DURING THE FORECAST PERIOD 33
FIGURE 15 STEM CELL MANUFACTURING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 34
FIGURE 16 STEM CELL LINES TO BE THE FASTEST-GROWING SEGMENT DURING 2018-2023 47
FIGURE 17 STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2018 VS. 2023 61
FIGURE 18 STEM CELL MANUFACTURING MARKET, BY END USER, 2018 VS. 2023 71
FIGURE 19 GEOGRAPHIC SNAPSHOT: ASIA PACIFIC TO BE THE FASTEST-GROWING REGION IN THE STEM CELL MANUFACTURING MARKET DURING THE FORECAST PERIOD 78
FIGURE 20 NORTH AMERICA: STEM CELL MANUFACTURING MARKET SNAPSHOT 80
FIGURE 21 EUROPE: STEM CELL MANUFACTURING MARKET SNAPSHOT 86
FIGURE 22 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET SNAPSHOT 91
FIGURE 23 ROW: STEM CELL MANUFACTURING MARKET SNAPSHOT 96
FIGURE 24 STEM CELL MANUFACTURING MARKET RANKING ANALYSIS,
BY KEY PLAYER (2016) 100
FIGURE 25 BD: COMPANY SNAPSHOT (2017) 106
FIGURE 26 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2016) 110
FIGURE 27 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2017) 114
FIGURE 28 LONZA GROUP: COMPANY SNAPSHOT (2016) 119
FIGURE 29 MEDIPOST: COMPANY SNAPSHOT (2016) 122
FIGURE 30 MERCK GROUP: COMPANY SNAPSHOT (2016) 124
FIGURE 31 PLURISTEM THERAPEUTICS: COMPANY SNAPSHOT (2016) 134
FIGURE 32 TAKARA BIO GROUP: COMPANY SNAPSHOT (2017) 142
FIGURE 33 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2016) 147
 

 

ページTOPに戻る

プレスリリース

[プレスリリース原文]

Stem Cell Manufacturing Market worth 14.61 Billion USD by 2023


March 13, 2018

The report "Stem Cell Manufacturing Market by Product (HSCs, MSCs, iPSCs, ESCs, Instruments, Media, Consumables), Application (Research, Target Identification, Therapy (Autologous, Allogeneic), Cell Banks), End User (Pharma, Hospitals) - Global Forecast to 2023", The report studies the global stem cell manufacturing market over the forecast period of 2018 to 2023. The market is projected to reach USD 14.61 Billion by 2023 from USD 10.75 Billion in 2018, at a CAGR of 6.3%. Factors such as growing public-private investments and funding in stem cell-based research, rising public awareness regarding about the therapeutic potency of stem cell products, development of advanced genomic analysis techniques for quality control during stem cell manufacturing, technological advancements in stem cell manufacturing and preservation, and evolving regulatory frameworks for stem cell therapeutics in the US and Europe are driving the growth of the stem cell manufacturing market.

Based on product, the stem cell lines segment is expected to witness the highest growth during the forecast period

On the basis of product, the stem cell manufacturing market is categorized into four major categories, namely, culture media, consumables, instruments, and stem cell lines. In 2017, the culture media segment accounted for the largest share of the market. This can be attributed to the rising stem cell research and increasing demand for stem cell therapies.

Based on application, the research applications segment accounted for the largest share of the stem cell manufacturing market in 2017

Based on application, the global stem cell manufacturing market is segmented into research applications, clinical applications, and cell and tissue banking. The research applications segment accounted for the largest share of the stem cell manufacturing in 2017. The growth in this segment is primarily attributed to the increasing focus on stem cell-based research, growing awareness about the therapeutic potency of stem cells, and public-private funding to support product development & commercialization.

By end user, cell and tissue banks are expected to witness the highest growth during the forecast period

On the basis of end user, the stem cell manufacturing market is segmented into pharmaceutical and biotech companies; hospital and surgical centers; academic institutes, research laboratories, and CROs; cell banks and tissue banks; and other end users. The pharmaceutical and biotech companies segment accounted for the largest share of the market in 2017. The large market share of this segment is primarily attributed to the rising public-private investments for stem cell-based research and ongoing patent expiry of branded drugs.

North America dominated the stem cell manufacturing market in 2017

Geographically, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America accounted for the largest share of the market in 2017. The high intensity of stem cell research in the region, rising public-private funding and grants to support the clinical evaluation of stem cells for various applications, robust research infrastructure, and rising public awareness on the therapeutic potency of stem cells are driving the growth of the stem cell manufacturing market in North America.

The major players in the market include Thermo Fisher Scientific (US), Merck Group (Germany), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Miltenyi Biotec (Germany), Takara Bio Group (Japan), STEMCELL Technologies (Canada), Pharmicell (South Korea), Osiris Therapeutics (US), Anterogen (South Korea), Cellular Dynamics International (US), MEDIPOST (South Korea), Lonza Group (Switzerland), Holostem Terapie Avanzate (Italy), and Pluristem Therapeutics (Israel), among others.

 

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る